Inside medical cannabis concentrates: hash and rosin reach the international shelf
In May 2026 the United Kingdom listed its first medical hash — Canadian-sourced static hash, crumble and ice-water hash — the clearest sign yet that concentrates are crossing from adult-use shelves into international medical markets. On our tracker that shelf is still gated by GMP-compliant supply, and price follows process, not potency: rosin holds a […]
Germany’s six-month gate: 82% of reimbursed cannabis at risk — and who stands to gain
On 10 July 2026 the Bundestag reshaped Germany’s reimbursed medical cannabis market — striking dried flower from statutory cover and gating extracts, dronabinol and nabilone behind a six-month trial of an approved finished medicine. On our figures that puts roughly €205 million — about 82% of a €248.8 million market — in play. This is […]
Inside Swiss medical cannabis: maturing beyond oils and pain — but who pays?
Switzerland’s 2022 reform made medical cannabis legally accessible to any prescriber, yet two years of federal MeCanna data reveal a market still defined by limited scale rather than open access. Beneath that constrained surface the picture is shifting: a patient base broadening beyond pain, and a product mix moving decisively toward flower. As adult-use pilots […]
Cannabinoids come of age: the clinical-trial pipeline behind Vertanical’s Exilby
Nearly 500 active clinical trials. A 3.5-fold rise in annual trial starts in five years. A decisive pivot away from CBD isolates toward whole-plant, THC-containing medicines aimed at pain. The German authorisation of Vertanical’s Exilby (VER-01) in 2026 — the first high-THC, full-spectrum botanical ever to win pharmaceutical marketing authorisation — is not just a […]
UK Medical Cannabis Market Doubles Again — and Flower Loses Share
The UK private medical cannabis market has scaled at a +113% CAGR through 2024. H1 2025 is tracking above 15 tonnes on Q2 run-rate. Behind the headline number, three structural shifts matter: growth rates are decelerating even as volumes still double, product mix is fragmenting beyond flower, and the binding constraints on further scaling are […]
Canada Ships 276 Tonnes of Medical Cannabis in 2025 — but Growth Signals Are Softening
276 tonnes of medical cannabis flower. C$643 million in export value. Roughly three-quarters of the world’s legal medical supply. Canada’s 2025 export data does not merely extend a growth trend — it redefines the country’s position in the global cannabis trade. In a single year, volumes more than doubled, a single regulatory event in Europe […]
Germany Imports 201 Tonnes of Medical Cannabis in 2025 and Crosses €1 Billion in Sales
Germany’s pharmacy sell-out market surpassed €1 billion for the first time in 2025, with imports reaching a record 201.1 tonnes (+176% YoY) — making it the largest regulated medical cannabis market globally. This data brief examines the supply chain diversification that accompanied that growth, the regulatory and pricing pressures now reshaping the operator landscape, the […]
Czechia’s medical cannabis programme gains momentum as GP reform widens access
Czechia’s medical cannabis programme grew 46% in 2025—the strongest year since 2021. Full-year SÚKL data confirms the GP reform partially worked: prescribing doctors rose 28% to 305, flower grew 35% (233 → 314 kg), and the extract market more than doubled (30 → 76 kg). Domestic EU-GMP producers now anchor supply, while Czech infrastructure increasingly […]
Spain’s CBD Boom Faces Hemp Sector Collapse and Regulatory Limbo
Between 2018 and 2023, Spain built one of Europe’s most dynamic CBD consumer markets. Revenues more than doubled, specialist shops appeared in every large city, and Spanish brands started exporting to neighbouring countries. Yet in the same period, the country almost eradicated the hemp crops that should be feeding that demand. What should be a […]
Spain Legalises Medical Cannabis: Patient Access Is the Next Frontier
After years of political delay and institutional hesitation, Spain has finally taken a decisive step toward a regulated medical cannabis system. Royal Decree 903/2025, published this summer, establishes the country’s first comprehensive framework for therapeutic use — a turning point that begins to align Spain with other advanced European markets. This article examines the foundations […]